A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : sIL-6R / soluble form of IL-6R

[Related PubMed/MEDLINE]
Total Number of Papers: 24
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   sIL-6R  (>> Co-occurring Abbreviation)
Long Form:   soluble form of IL-6R
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Interleukin-6: A Masterplayer in the Cytokine Network. IL-6, iMCD
2018 Physiological effects of modulating the interleukin-6 axis. IL-6R
2017 Enhancing Interleukin-6 and Interleukin-11 receptor cleavage. IL-11R, IL-6R
2016 Circulating Soluble IL-6R but Not ADAM17 Activation Drives Mononuclear Cell Migration in Tissue Inflammation. ---
2014 Interleukin-6 and its receptors: a highly regulated and dynamic system. gp130, IL-6, sgp130
2012 IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. IL-6, IL-6R
2011 The soluble Interleukin 6 receptor: generation and role in inflammation and cancer. ADAM, IL-6, IL-6R, sgp130
2011 The structure of the unliganded extracellular domain of the interleukin-6 signal transducer gp130 in solution. IL-6, IL-6R, SAXS
2008 IL-6/IL-6R axis plays a critical role in acute kidney injury. AKI, IL-6R
10  2008 Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130. gp130, IL-6, sgp130
11  2007 Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cells. mIL-6R, OVA, STAT
12  2007 Novel role of IL-6/SIL-6R signaling in the expression of inducible nitric oxide synthase (iNOS) in murine B16, metastatic melanoma clone F10.9, cells. iNOS, JNK, MAPK
13  2007 The IL-6/sIL-6R complex as a novel target for therapeutic approaches. mIL-6R, CD126
14  2004 Interleukin-6/soluble interleukin-6 receptor signaling attenuates proliferation and invasion, and induces morphological changes of a newly established pleomorphic malignant fibrous histiocytoma cell line. gp130, IL, IL-6R, MAPK, MFH, PNS, STAT3
15  2003 Anti-interleukin-6 therapy for Crohn's disease. CD, IFN-gamma, IL-6, IL-6R, LP, mAb, TGF-beta, TNF-alpha
16  2003 IL-6 and Crohn's disease. IL-6, mAb
17  2001 Directly linked soluble IL-6 receptor-IL-6 fusion protein induces astrocyte differentiation from neuroepithelial cells via activation of STAT3. GFAP, IL-6, IL-6R, LIF, STAT3
18  2000 Role of different dialysis membranes in the release of interleukin-6-soluble receptor in uremic patients. CU, IL-6, IL-6R, PBMC, PMMA, UR
19  1999 Disulfide bond structure and N-glycosylation sites of the extracellular domain of the human interleukin-6 receptor. FNIII, IL-6, IL-6R
20  1999 Role of soluble interleukin-6 receptor in inflamed gingiva for binding of interleukin-6 to gingival fibroblasts. GF, IL-6, IL-6R
21  1998 Human myeloma cells shed the interleukin-6 receptor: inhibition by tissue inhibitor of metalloproteinase-3 and a hydroxamate-based metalloproteinase inhibitor. IL-6, IL-6R, MM, PMA, TIMP
22  1998 In vivo and in vitro activities of the gp130-stimulating designer cytokine Hyper-IL-6. IL-6R
23  1998 Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression. BBB, CNS
24  1995 Soluble interleukin-6 receptor strongly increases the production of acute-phase protein by hepatoma cells but exerts minimal changes on human primary hepatocytes. APP, IL-6